<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="17230">Homocysteine</z:chebi>, a <z:chebi fb="0" ids="26834">sulfur-containing amino acid</z:chebi>, is a metabolite of the essential amino acid methionine </plain></SENT>
<SENT sid="1" pm="."><plain>High blood levels of <z:chebi fb="0" ids="17230">homocysteine</z:chebi> result in far-reaching biochemical and life-threatening consequences </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="17230">Homocysteine</z:chebi> exists at a critical biochemical intersection in the methionine cycle between S-adenosylmethionine, the ubiquitous <z:chebi fb="36" ids="29309">methyl</z:chebi> donor, and vitamins B(12) and <z:chebi fb="9" ids="27470">folic acid</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Indirect and direct vascular damage can be caused by <z:chebi fb="0" ids="17230">homocysteine</z:chebi>, a putative atherothrombotic risk factor </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="17230">Homocysteine</z:chebi> has been associated with <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e>, particularly in subjects with significant <z:hpo ids='HP_0100546'>carotid stenosis</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Increasing evidence for a connection between <z:chebi fb="0" ids="17230">homocysteine</z:chebi> metabolism and cognitive function is surfacing, and this includes from mild <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> (age-related <z:hpo ids='HP_0002354'>memory loss</z:hpo>) to vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> and <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>In the elderly population increase in <z:chebi fb="0" ids="17230">homocysteine</z:chebi> is commonly seen due to significant deficiencies in <z:chebi fb="1" ids="30411">cobalamin</z:chebi> (B(12)), <z:chebi fb="3" ids="37445">folate</z:chebi> and vitamin B(6.) <z:hpo ids='HP_0000001'>All</z:hpo> of these disease associations are thought to be interrelated via increased <z:chebi fb="0" ids="17230">homocysteine</z:chebi> and S-adenosylhomocysteine and subsequent hypomethylation of numerous substances, including DNA and proteins, rendering vascular structures more susceptible to damage </plain></SENT>
<SENT sid="7" pm="."><plain>Decreasing plasma <z:chebi fb="0" ids="17230">homocysteine</z:chebi>, by providing nutritional cofactors for its metabolism has been shown to reduce the risk of cardiovascular events </plain></SENT>
<SENT sid="8" pm="."><plain>The current methods of evaluation of <z:chebi fb="0" ids="17230">homocysteine</z:chebi> metabolism include assessment of <z:chebi fb="1" ids="30411">cobalamin</z:chebi> (B(12)) and <z:chebi fb="3" ids="37445">folate</z:chebi> and vitamin B(6) status and screening for mutations in the genes encoding the enzymes of metabolism </plain></SENT>
<SENT sid="9" pm="."><plain>An accurate method for the estimation of plasma and tissue levels of <z:chebi fb="0" ids="17230">homocysteine</z:chebi> would contribute greatly to a proper understanding of the metabolism </plain></SENT>
<SENT sid="10" pm="."><plain>In the current review emphasis will be on the estimation of <z:chebi fb="0" ids="17230">homocysteine</z:chebi>, and evaluation of one of the common mutations encountered in the metabolism of this amino acid </plain></SENT>
</text></document>